PGR and breast cancer: The mechanistic insights we revealed by large scale coregulator recruitment assays, transcriptomic and protein analysis demonstrate a 50–100 times lower potency of E4 versus E2 to activate the recruitment of coregulators to ERα, to induce similar transcriptional activity and to sustain progesterone receptor (PR) expression in breast cancer.